Latest Earnings Results: Q3 '26
Estimated EPS
-$0.08
Reported EPS
-$0.10
Surprise
-28.21%
Estimated Rev
$11.51M
Reported Rev
$12.33M
Surprise
+7.13%
Myomo expects revenues to continue to grow in 2026, primarily as a result of investments in recurring patient sources, including MyoConnect referrals and O&P practices in the U.S. and Germany.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.06 | -- | -- | N/A |
Q3 '26 | -$0.08 | -$0.10 | -28.21% | MISSED |
Q2 '26 | -$0.10 | -$0.09 | 8.16% | BEAT |
Q1 '26 | -$0.11 | -$0.07 | 38.60% | BEAT |
Q4 '25 | -$0.09 | -$0.09 | -4.65% | MISSED |